Assessment of serum periostin level as a predictor of requirement for intensive treatment for type-2 inflammation in asthmatics in future: A follow-up study of the KiHAC cohort.
Sunadome H, Matsumoto H, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Iwanaga T, Hozawa S, Niimi A, Kanemitsu Y, Nagasaki T, Tashima N, Ishiyama Y, Morimoto C, Oguma T, Tajiri T, Ito I, Ono J, Ohta S, Izuhara K, Hirai T.
Sunadome H, et al. Among authors: ishiyama y.
Allergol Int. 2021 Apr;70(2):252-254. doi: 10.1016/j.alit.2020.10.006. Epub 2020 Nov 18.
Allergol Int. 2021.
PMID: 33218953
Free article.
No abstract available.